Circulatory assistance in acute heart failure – where do we go from here?

References

• Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, van der Werf F, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial. JAMA. 2007; 297: 1657–66
   PubMed Web of Science ®Google Scholar
• Moses LE. The series of consecutive cases as a device for assessing outcome of interventions. Medical uses of statistics2nd ed, JC III Bailar, F Mosteller. NEJM Books, Boston, MA 2000; 125–141
   Google Scholar
• Linden, H, Wiklund, L, Haraldsson, Å, Berglin, E, Hultman, J, Dellgran, G. Temporary circulatory support with ECMO in adults with refractory cardiogenic shock. Scand Cardiovasc J. 2009, (this issue).
   Web of Science ®Google Scholar
• Granfeldt, H, Hellgren, L, Dellgren, G, Myrdal, G, Wassberg, G, Kjellman, U, et al. The Impella® recovery axial-flow system for acute heart failure at three cardiothoracic centers in Sweden. Scand Cardiovasc J. 2009, (this issue).
   Web of Science ®Google Scholar
• Bartlett RH, Gazzaniga AB, Fong SW, Jefferies MR, Roohk HV, Haiduc N. Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases. J Thorac Cardiovasc Surg. 1977; 73: 375–86
   PubMed Web of Science ®Google Scholar
• UK Collaborative ECMO Trail Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet. 1996; 348: 75–82
   PubMed Web of Science ®Google Scholar
• Chaturvedi RR, Macrae D, Brown KL, Schindler M, Smith EC, Davis KB, et al. Cardiac ECMO for biventricular hearts after paediatric open heart surgery. Heart. 2004; 90: 545–51
   PubMed Web of Science ®Google Scholar
• Thourani VH, Kirshbom PM, Kanter KR, Simsic J, Kogon BE, Wagoner BE, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support. Ann Thorac Surg. 2006; 82: 138–44
   PubMed Web of Science ®Google Scholar
• Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979; 242: 2193–6
   PubMed Web of Science ®Google Scholar
• Morris AH, Wallace CJ, Menlove RL, Clemmer TP, Orme JF, Weaver LK, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994; 149: 295–305
   PubMed Web of Science ®Google Scholar
• Nichol G, Karmy-Jones R, Salerno C, Cantore L, Becker L. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation. 2006; 70: 381–94
   PubMed Web of Science ®Google Scholar
• Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: Survival at five years. J Thorac Cardiovasc Surg. 2001; 122: 92–102
   PubMed Web of Science ®Google Scholar
• Chen JS, Ko WJ, Yu HY, Lai LP, Huang SC, Chi NH, et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med. 2006; 34: 950–7
   PubMed Web of Science ®Google Scholar
• Doll N, Fabricius A, Borger MA, Bucerices J, Kramer K, Doll S, et al. Temporary extracorporeal membrane oxygenation in patients with refractory postoperative cardiogenic shock–a single center experience. J Card Surg. 2003; 18: 512–8
   PubMed Web of Science ®Google Scholar
• Doll N, Kiaii B, Borger M, Bucerices J, Kramer K, Schmitt DV, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004; 77: 151–7
   PubMed Web of Science ®Google Scholar
• Chen YS, Lin JW, Yu HY, Ko WJ, Jeng JS, Chang WT, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: An observational study and propensity analysis. Lancet. 2008; 372: 554–61
   PubMed Web of Science ®Google Scholar
• Hoefer D, Ruttmann E, Poelzl G, Kilo J, Hoermann C, Margreiter R, et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg. 2006; 82: 28–33
   PubMed Web of Science ®Google Scholar
• Taghavi S, Zuckermann A, Ankersmit J, Wieselhaker G, Rajek A, Laufer G, et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg. 2004; 78: 1644–9
   PubMed Web of Science ®Google Scholar
• Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26: 1276–83
   PubMed Web of Science ®Google Scholar
• Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006; 152: 469–8
   PubMedGoogle Scholar
• Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W. Initial experiences with the Impella device in patients with cardiogenic shock – Impella support for cardiogenic shock. Thorac Cardiovasc Surg. 2003; 51: 312–7
   PubMed Web of Science ®Google Scholar
• Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg. 2004; 77: 1642–7
   PubMed Web of Science ®Google Scholar
• Garatti A, Colombo T, Russo C, Lanfranconi M, Milazzo F, Catena E, et al. Left ventricular mechanical support with the Impella Recover left direct microaxial blood pump: A single-center experience. Artif Organs. 2006; 30: 523–8
   PubMed Web of Science ®Google Scholar
• Seyfarth M, Sibbing D, Bauer I, Frolich G, Bott-Flugel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52: 1584–8
   PubMed Web of Science ®Google Scholar
• Siegenthaler MP, Brehm K, Strecker T, Hanke T, Notzold A, Olschewski M, et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: A three-center experience. J Thorac Cardiovasc Surg. 2004; 127: 812–22
   PubMed Web of Science ®Google Scholar
• Merhige ME, Smalling RW, Cassidy D, Barrett R, Wise G, Short J, et al. Effect of the hemopump left ventricular assist device on regional myocardial perfusion and function. Reduction of ischemia during coronary occlusion. Circulation. 1989; 80: 158–66
   PubMed Web of Science ®Google Scholar
• Baldwin RT, Radovancevic B, Conger JL, Matsunaka R, Duncan JM, Vaughn WK, et al. Peripheral organ perfusion augmentation during left ventricular failure. A controlled bovine comparison between the intraaortic balloon pump and the Hemopump. Tex Heart Inst J. 1993; 20: 275–80
   PubMed Web of Science ®Google Scholar
• Smalling RW, Cassidy DB, Barrett R, Lachterman B, Felli P, Amirian J. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation. 1992; 85: 1152–9
   PubMed Web of Science ®Google Scholar
• Scholz KH, Hering JP, Schroder T, Uhlig P, Kreuzer H, Hellige G. Left-ventricular unloading by transvalvular axial flow pumping in experimental cardiogenic shock and during regional myocardial ischemia. Cardiology. 1994; 84: 202–10
   PubMed Web of Science ®Google Scholar
• Sauren LD, Accord RE, Hamzeh K, de Jong M, van der Nagel T, van der Veen FH, et al. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: An experimental study. Artif Organs. 2007; 31: 839–42
   PubMed Web of Science ®Google Scholar
• Marks JD, Pantalos GM, Long JW, Kinoshita M, Everett SD, Olsen DB. Myocardial mechanics, energetics, and hemodynamics during intraaortic balloon and transvalvular axial flow hemopump support with a bovine model of ischemic cardiac dysfunction. ASAIO J. 1999; 45: 602–9
   PubMed Web of Science ®Google Scholar
• Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: Experience with the Abiomed BVS system. J Card Surg. 1999; 14: 288–93
   PubMed Web of Science ®Google Scholar
• Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, et al. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002; 106: 203–6
   PubMed Web of Science ®Google Scholar
• Samuels LE, Holmes EC, Thomas MP, Entwistle JC, Morris RJ, Narula J, et al. Management of acute cardiac failure with mechanical assist: Experience with the ABIOMED BVS 5000. Ann Thorac Surg. 2001; 71: 67–72
   PubMed Web of Science ®Google Scholar
• Jeger RV, Lowe AM, Buller CE, Pfisterer ME, Dzavik V, Webb JG, et al. Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: A report from the SHOCK trial. Chest. 2007; 132: 1794–803
   PubMed Web of Science ®Google Scholar
• Potapov EV, Loforte A, Weng Y, Jurmann M, Pasic M, Drew ST, et al. Experience with over 1000 implanted ventricular assist devices. J Card Surg. 2008; 3: 185–94
   Google Scholar
• Felker GM, Cotter G. Unraveling the pathophysiology of acute heart failure: An inflammatory proposal. Am Heart J. 2006; 151: 765–7
   PubMed Web of Science ®Google Scholar
• Hochman JS. Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation. 2003; 107: 2998–3002
   PubMed Web of Science ®Google Scholar
• Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005; 165: 1643–50
   PubMed Web of Science ®Google Scholar
• Graulich J, Sonntag J, Marcinkowski M, Bauer K, Kossel H, Buhrer C, et al. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation. Mediators Inflamm. 2002; 11: 69–73
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983; 86: 845–57
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, O'Donnell M. Pexelizumab does not “complement” percutaneous coronary intervention in patients with ST-elevation myocardial infarction. JAMA. 2007; 297: 91–2
   PubMed Web of Science ®Google Scholar
• Testa L, Van Gaal WJ, Bhindi R, Biondi-Zoccai GG, Abbate A, Agostoni P, et al. Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients. J Thorac Cardiovasc Surg. 2008; 136: 884–93
   PubMed Web of Science ®Google Scholar
• Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003; 107: 3133–40
   PubMed Web of Science ®Google Scholar
• Haverich A, Shernan SK, Levy JH, Chen JC, Carrier M, Taylor KM, et al. Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. Ann Thorac Surg. 2006; 82: 486–92
   PubMed Web of Science ®Google Scholar
• Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, et al. Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004; 109: 1594–602
   PubMed Web of Science ®Google Scholar
• Hermansen SE, Hansen M, Roaldsen M, Muller S, How OJ, Myrmel T. How many acute heart failure patients need a ventricular assist device?. Scand Cardiovasc J. 2008; 42: 118–24
   PubMed Web of Science ®Google Scholar
• Bachet J. The potatoes and the bottle. Eur J Cardiothorac Surg. 2004; 25: 242–245
   Web of Science ®Google Scholar